CPIX (STOCKS)
Cumberland Pharmaceuticals Inc
$3.120000
+0.030000 (+0.97%)
Prev close: $3.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- A. J. Kazimi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $46.66M
- Employees
- 91
- P/E (TTM)
- -16.31
- P/B (TTM)
- 1.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.01 | $0.00 | +0.0000 | +0.00% |
|
Sep 2025 (Q3)
|
$-0.06 | $0.00 | +0.0000 | +0.00% |
|
Jun 2025 (Q2)
|
$0.02 | $0.00 | +0.0000 | +0.00% |
|
Mar 2025 (Q1)
|
$0.16 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $44.52M |
| Benefits Costs and Expenses | $47.33M |
| Cost Of Revenue | $6.67M |
| Costs And Expenses | $47.31M |
| Gross Profit | $37.85M |
| Operating Expenses | $40.65M |
| Research and Development | $5.57M |
| Other Operating Expenses | $35.08M |
| Operating Income/Loss | -$2.79M |
| Income/Loss Before Equity Method Investments | -$2.81M |
| Income/Loss From Continuing Operations After Tax | -$2.86M |
| Income/Loss From Continuing Operations Before Tax | -$2.81M |
| Income/Loss From Equity Method Investments | -$13.22K |
| Income Tax Expense/Benefit | $40.26K |
| Income Tax Expense/Benefit, Current | $40.00K |
| Interest Expense, Operating | $495.99K |
| Net Income/Loss | -$2.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$28.58K |
| Net Income/Loss Attributable To Parent | -$2.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.19 |
| Diluted Earnings Per Share | -$0.19 |
| Basic Average Shares | 14,854,619 |
| Diluted Average Shares | 14,854,619 |
| Assets | $76.82M |
| Current Assets | $37.06M |
| Inventory | $6.23M |
| Other Current Assets | $30.83M |
| Noncurrent Assets | $39.76M |
| Fixed Assets | $264.72K |
| Other Non-current Assets | $39.50M |
| Liabilities | $52.28M |
| Current Liabilities | $36.74M |
| Accounts Payable | $18.57M |
| Wages | $1.48M |
| Other Current Liabilities | $16.70M |
| Noncurrent Liabilities | $15.53M |
| Equity | $24.54M |
| Equity Attributable To Noncontrolling Interest | -$336.10K |
| Equity Attributable To Parent | $24.88M |
| Liabilities And Equity | $76.82M |
| Net Cash Flow From Operating Activities | $4.93M |
| Net Cash Flow From Operating Activities, Continuing | $4.93M |
| Net Cash Flow From Investing Activities | -$4.71M |
| Net Cash Flow From Investing Activities, Continuing | -$4.71M |
| Net Cash Flow From Financing Activities | -$6.75M |
| Net Cash Flow From Financing Activities, Continuing | -$6.75M |
| Net Cash Flow | -$6.52M |
| Net Cash Flow, Continuing | -$6.52M |
| Comprehensive Income/Loss | -$2.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.86M |
| Other Comprehensive Income/Loss | $0.00 |